Document Detail


Acute respiratory distress syndrome in children with acute iron poisoning: the role of intravenous desferrioxamine.
MedLine Citation:
PMID:  10664227     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
CONCLUSION: We believe that the efficacy and safety of chelation therapy in severe acute iron poisoning may be improved by targeting the initial high levels of readily chelatable serum iron with adequate doses of desferrioxamine without prolonging its use unnecessarily.
Authors:
A S Ioannides; J M Panisello
Related Documents :
19423367 - Animal poisoning in europe. part 3: wildlife.
16989927 - Benzene exposure in the shoemaking industry in china, a literature survey, 1978-2004.
9776967 - Carisoprodol-induced myoclonic encephalopathy.
21516017 - Multicentric infantile hemangiopericytoma: case report and review of the literature.
8311057 - Deaths involving the benzodiazepine flunitrazepam.
1382007 - Psychosis and idiopathic precocious puberty in two 7-year-old boys.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  European journal of pediatrics     Volume:  159     ISSN:  0340-6199     ISO Abbreviation:  Eur. J. Pediatr.     Publication Date:  2000 Mar 
Date Detail:
Created Date:  2000-04-05     Completed Date:  2000-04-05     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  7603873     Medline TA:  Eur J Pediatr     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  158-9     Citation Subset:  IM    
Affiliation:
Department of Paediatric Intensive Care, Royal Manchester Children's Hospital, Hospital Road, Pendlebury, Manchester M27 4HA, UK. aioannides@aioannides.ndirect.co.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Chelating Agents / administration & dosage*,  adverse effects,  therapeutic use
Child, Preschool
Deferoxamine / administration & dosage*,  adverse effects,  therapeutic use
Female
Humans
Infusions, Intravenous
Iron / poisoning*
Respiratory Insufficiency / etiology*
Chemical
Reg. No./Substance:
0/Chelating Agents; 70-51-9/Deferoxamine; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Plasma concentrations of granulocyte-macrophage colony-stimulating factor and interleukin-6 in septi...
Next Document:  Japanese patients with sporadic Hirschsprung: mutation analysis of the receptor tyrosine kinase prot...